[1] |
Tsunemi Y,Irisawa R,Yoshiie H, et al. Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia[J]. J Dermatol, 2016,43(9):1051-1058.
|
[2] |
Ramos PM,Miot HA. Female pattern hair loss: a clinical and pathophysiological review[J]. An Bras Dermatol, 2015,90(4):529-543.
|
[3] |
Alves R,Grimalt R. A review of platelet-rich plasma: history, biology, mechanism of action, and classification[J]. Skin Appendaqe Disord, 2018,4(1):18-24.
|
[4] |
Giannini S,Cielo A,Bonanome L, et al. Comparison between PRP, PRGF and PRF: lights and shadows in three similar but different protocols[J]. Eur Rev Med Pharmacol Sci, 2015,19(6):927-930.
|
[5] |
Bernardi S,Mummolo S,Tecco S, et al. Histological characterization of sacco′s concentrated growth factors membrane[J]. Int J Morphol, 2017,35(1):114-119.
|
[6] |
Qiao J,An N,Ouyang X. Quantification of growth factors in different platelet concentrates[J]. Platelets, 2017,28(8):774-778.
|
[7] |
Mariaangeliki G,Alexandros-Efstratios K,Dimitris R, et al. Platelet-rich plasma as a potential treatment for noncicatricial alopecias[J]. Int J Trichology, 2015,7(2):54-63.
|
[8] |
Masuki H,Okudera T,Watanebe T, et al. Growth factor and pro-inflammatory cytokine contents in platelet-rich plasma (PRP), plasma rich in growth factors (PRGF), advanced platelet-rich fibrin (A-PRF), and concentrated growth factors (CGF)[J]. Int J Implant Dent, 2016,2(1):19.
|
[9] |
Romano F,Rizzo BA,Sacco L, et al. A novel use of growth factors, CD34 positive cells, and fibrin for fingertip injury: Description of a case[J]. J Dermatol Dermatologic Surgery, 2016,20(1):62-64.
|
[10] |
Mihaylova Z,Tsikandelova R,Sanimirov P, et al. Role of PDGF-BB in proliferation, differentiation and maintaining stem cell properties of PDL cells in vitro[J]. Arch Oral Biol, 2018,85:1-9.
|
[11] |
Kamp H,Geilen CC,Sommer C, et al. Regulation of PDGF and PDGF receptor in cultured dermal papilla cells and follicular keratinocytes of the human hair follicle[J]. Exp Dermatol, 2003,12(5):662-672.
|
[12] |
Tomita Y,Akiyama MH,Shimizu H. PDGF isoforms induce and maintain anagen phase of murine hair follicles[J]. J Dermatol Sci, 2006,43(2):105-115.
|
[13] |
Ceruti JM,Leirós GJ,Balañá ME. Androgens and androgen receptor action in skin and hair follicles[J]. Mol Cell Endocrinol, 2018,465:122-133.
|
[14] |
Hou-Dong L,Bin S,Ying-Bin X, et al. Differentiation of rat dermal papilla cells into fibroblast-like cells induced by transforming growth factor-β1[J]. J Cutan Med Surg, 2012,16(6):400-406.
|
[15] |
Xu ZC,Zhang Q,Li H. Human hair follicle stem cell differentiation into contractile smooth muscle cells is induced by transforming growth factor-β1 and platelet-derived growth factor BB[J]. Mol Med Rep, 2013,8(6):1715-1721.
|
[16] |
Herman A,Herman AP. Mechanism of action of herbs and their active constituents used in hair loss treatment[J]. Fitoterapia, 2016,114:18-25.
|
[17] |
Quan R,Du W,Zheng X, et al. VEGF165 induces differentiation of hair follicle stem cells intoendothelial cells and plays a role in in vivo angiogenesis[J]. J Cell Mol Med, 2017,21(8):1593-1604.
|
[18] |
Gnann LA,Castro RF,Azzalis LA, et al. Hematological and hepatic effects of vascular epidermal growth factor (VEGF) used to stimulate hair growth in an animal model[J]. BMC Dermatol, 2013,13:15.
|
[19] |
Bai T,Liu F,Zou F, et al. Epidermal growth factor induces proliferation of hair follicle-derived mesenchymal stem cells through epidermal growth factor receptor-mediated activation of ERK and AKT signaling pathways associated with upregulation of cyclin D1 and downregulation of p16[J]. Stem Cells Dev, 2017,26(2):113-122.
|
[20] |
Zhang H,Nan W,Wang S, et al. Epidermal growth factor promotes proliferation of dermal papilla cells via Notch signaling pathway[J]. Biochimie, 2016,127:10-18.
|
[21] |
Zhang H,Nan W,Wang S, et al. Epidermal growth factor promotes proliferation and migration of follicular outer root sheath cells via Wnt/β-catenin signaling[J]. Cell Physiol Biochem, 2016,39(1):360-370.
|
[22] |
Herman A,Herman AP. Mechanism of action of herbs and their active constituents used in hair loss treatment[J]. Fitoterapia, 2016,114:18-25.
|
[23] |
Li J,Yang Z,Li Z, et al. Exogenous IGF-1 promotes hair growth by stimulating cell proliferation and down regulating TGF-β1 in C57BL/6 mice in vivo[J]. Growth Horm IGF Res, 2014,24(2-3):89-94.
|
[24] |
Panchaprateep R,Asawanonda P. Insulin-like growth factor-1: roles in androgenetic alopecia[J]. Exp Dermatol, 2014,23(3):216-218.
|
[25] |
Kawano M,Umeda S,Yasuda T, et al. FGF18 signaling in the hair cycle resting phase determines radioresistance of hair follicles by arresting hair cycling[J]. Adv Radiat Oncol, 2016,1(3):170-181.
|
[26] |
Lin WH,Xiang LJ,Shi HX, et al. Fibroblast growth factors stimulate hair growth through β-Catenin and Shh expression in C57BL/6 mice[J]. Biomed Res Int, 2015:730139.
|
[27] |
Kiso M,Hamazaki TS,Itoh M, et al. Synergistic effect of PDGF and FGF2 for cell proliferation and hair inductive activity in murine vibrissal dermal papilla in vitro[J]. J Dermatol Sci, 2015,79(2):110-118.
|
[28] |
Lindner G,Menrad A,Gherardi E, et al. Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling[J]. FASEB J, 2000,14(2):319-332.
|
[29] |
Mcelwee KJ,Huth A,Kissling S, et al. Macrophage-stimulating protein promotes hair growth ex vivo and induces anagen from telogen stage hair follicles in vivo[J]. J Invest Dermatol, 2004,123(1):34-40.
|
[30] |
Qi Y,Li M,Xu L, et al. Therapeutic role of human hepatocyte growth factor (HGF) in treating hair loss[J]. Peer J, 2016,4:e2624.
|
[31] |
Sidney LE,Branch MJ,Dunphy SE, et al. Concise review: evidence for CD34 as a common marker for diverse progenitors[J]. Stem Cells, 2014,32(6):1380-1389.
|
[32] |
Garza LA,Yang CC,Zhao T, et al. Bald scalp in men with androgenetic alopecia retains hair follicle stem cells but lacks CD200-rich and CD34-positive hair follicle progenitor cells[J]. J Clin Invest, 2011,121(2):613-622.
|
[33] |
Kang JS,Zheng Z,Choi MJ, et al. The effect of CD34+ cell-containing autologous platelet-rich plasma injection on pattern hair loss: a preliminary study[J]. J Eur Acad Dermatol Venereol, 2014,28(1):72-79.
|
[34] |
Kushida S,Kakudo N,Morimoto N, et al. Platelet and growth factor concentrations in activated platelet-rich plasma: a comparison of seven commercial separation systems[J]. J Artif Organs, 2014,17(2):186-192.
|
[35] |
Kramer ME,Keaney TC. Systematic review of platelet-rich plasma (PRP) preparation and composition for the treatment of androgenetic alopecia[J]. J Cosmet Dermatol, 2018,doi: 10.1111/jocd.12679.[Epub ahead of print].
|
[36] |
Adil A,Godwin M. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis[J]. J Am Acad Dermatol, 2017,77(1):136-141.
|
[37] |
Starace M,Alessandrini A,D′Acunto C, et al. Platelet-rich plasma on female androgenetic alopecia: Tested on 10 patients[J]. J Cosmet Dermatol, 2018,doi: 10.1111/jocd.12550.[Epub ahead of print].
|
[38] |
Jha AK,Udayan UK,Roy PK, et al. Original article: Platelet-rich plasma with microneedling in androgenetic alopecia along with dermoscopic pre- and post-treatment evaluation[J]. J Cosmet Dermatol, 2018,17(3):313-318.
|
[39] |
Anitua E,Pino A,Jaén P, et al. Platelet rich plasma for the management of hair loss: Better alone or in combination[J]. J Cosmet Dermatol, 2018,doi: 10.1111/jocd.12683. [Epub ahead of print].
|